Plasma Polymerized Silicon Coating for Biocompatible Medical Surfaces
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical and sensor technologies face challenges in producing non-genotoxic surfaces that are biocompatible and resistant to biomolecule and cell adhesion, particularly for long-term contact with the body, as existing methods are costly, complex, and often result in undesirable interactions leading to inflammation and bacterial colonization.
Innovation Solution
A cross-linked silicon-containing layer, composed of silicon, oxygen, carbon, hydrogen, and optionally nitrogen, produced by plasma polymerization or UV radiation without metals of atomic number greater than 14, is used to create a non-genotoxic surface that adjusts biomolecule and cell adhesion, ensuring non-genotoxicity and biocompatibility while being easy to produce and apply to complex shapes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional wet chemical and physical surface treatment processes are used to improve biocompatibility, then surface properties such as protein adhesion and cell attachment are improved, but the production process becomes laborious and complex
Solution Approach 1:
The patent replaces complex wet chemical and physical surface treatment processes with a simple plasma polymerization process. The plasma process uses reactive species and UV radiation to deposit biocompatible coatings directly onto surfaces, eliminating the need for multiple chemical treatment steps, rinsing, and drying operations. This substitution of chemical-mechanical processes with a plasma-based physical-chemical process resolves the contradiction between achieving reliable biocompatibility and maintaining simple production processes.
Solution Approach 2:
The patent utilizes plasma parameters such as power, pressure, gas composition, and exposure time to control the deposition and properties of the biocompatible coating. By adjusting these parameters, the coating composition, thickness, and surface properties can be optimized for specific biocompatibility requirements. This parameter control allows achievement of reliable biocompatibility through a single, well-controlled plasma process rather than through complex multi-step conventional treatments.
2Object-affected harmful factors
If plasma polymerization is used to produce non-genotoxic surfaces, then non-genotoxicity and biocompatibility are achieved, but the process requires specific equipment and process control
Solution Approach 1:
The plasma polymerization process is conducted in a vacuum chamber with controlled atmosphere, typically using inert or reactive gases such as oxygen, nitrogen, or silane-containing gases. This controlled inert environment prevents contamination and ensures consistent coating properties while eliminating genotoxic risks associated with conventional chemical treatments. The inert atmosphere approach resolves the contradiction by providing a clean, controlled environment that achieves non-genotoxicity while maintaining reasonable process simplicity through standard plasma equipment.
3Reliability
If surfaces are treated to promote cell attachment and tissue integration, then biocompatibility and healing are improved, but the risk of inflammation and rejection increases
Solution Approach 1:
The plasma polymerization process can create surfaces with locally optimized properties by controlling plasma exposure patterns and gas composition. Different regions of a surface can be treated with different plasma conditions to achieve specific local properties - for example, high cell attachment areas for tissue integration and low adhesion areas for preventing bacterial colonization. This local quality approach allows simultaneous achievement of tissue integration and inflammation prevention by optimizing surface properties in different locations.
Solution Approach 2:
The plasma-coated surfaces can incorporate multiple functional groups and chemical compositions within a single coating layer. By using composite plasma coatings with tailored molecular structures, the surface can simultaneously provide cues for cell attachment and tissue integration while maintaining anti-inflammatory and anti-rejection properties. The composite nature of the plasma coating allows integration of multiple beneficial functions that resolve the contradiction between promoting tissue integration and preventing harmful immune responses.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides a non-genotoxic, biocompatible surface that reduces biomolecule and cell adhesion, preventing inflammation and bacterial colonization, while being cost-effective and suitable for various medical and sensor applications, ensuring safe and effective long-term contact with the body.
Implementation Method 1
which can be produced by plasma polymerization and/or cross-linking of organosilicon liquids by a plasma process
Implementation Method 2
and/or UV radiation of a wavelength of less than 250 nm
Data Source
AI summary
The present invention relates to the use of a crosslinked, silicon-containing layer containing, substantially consisting of or consisting of silicon, O, C, H, optionally N which can be produced by plasma polymerization and/or crosslinking of organosilicon liquids by a plasma process and/or UV radiation of a wavelength of less than 250 nm, without using metals of an atomic number of more than 14, as a biocompatible surface, for imparting to a surface or providing a surface with a non-genotoxic effect. The invention also relates to correspondingly coated articles and to processes for the production thereof.